LAB Q1 2020 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M-8.3% YoY

Gross Profit

$16M59.6% margin

Operating Income

-$15M-54.1% margin

Net Income

-$16M-57.9% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-14.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$290M

Total Liabilities

$149M

Stockholders' Equity

$141M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$30M	-8.3%
Gross Profit	$16M	$17M	-3.2%
Operating Income	-$15M	-$14M	-5.2%
Net Income	-$16M	-$25M	+37.2%

Revenue Segments

Product

$19M44%

Consumables

$10M22%

Instruments

$9M22%

Service

$5M12%

Grant Revenue

$350,0001%

Geographic Segments

Americas

$15M54%

EMEA

$8M29%

Asia Pacific

$5M17%